Breaking

Wi-Fi HaLow Market Shows Promise With Steady Growth Projected Through 2029
Commencement of Henbury Field Program
RCM to Acquire Webbs Consol Silver Project from Lode Res.
Crypto Market Update: Stablecoins Top US$283 Billion in Circulation, Bitcoin Decline Continues
Tech 5: NVIDIA Results Rattle Investors, Trump Signals More Tech Deals to Come
Spirit Airlines files for Chapter 11 bankruptcy protection for the second time in a year
Top 5 Canadian Mining Stocks This Week: Trifecta Shines with 117 Percent Gain
Retail panic: What the end of the ‘de minimis’ exemption means for brands across the globe

Facebook
Twitter
Google Plus
Instagram
Pinterest
Vimeo

Investing
Stock
Latest News
Editor’s Pick
Economy
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

By December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Commencement of Henbury Field Program

September 1, 2025

RCM to Acquire Webbs Consol Silver Project from Lode Res.

September 1, 2025

Crypto Market Update: Stablecoins Top US$283 Billion in Circulation, Bitcoin Decline Continues

August 31, 2025

Enter Your Information Below To Receive Latest News, And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest Posts
Categories
- Economy (986)
- Editor's Pick (535)
- Investing (4,014)
- Latest News (3,536)
- Stock (1,161)
About Rightinvestingway

Disclaimer: Rightinvestingway.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Rightinvestingway.com

Top

Type above and press Enter to search. Press Esc to cancel.